Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia
- PMID: 305461
- PMCID: PMC2184196
- DOI: 10.1084/jem.147.3.912
Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia
Abstract
Short-term culture of acute myelogenous leukemia patient's remission lymphocytes with inactivated autologous leukemic blast cells plus allogeneic lymphocytes, generated effector T lymphocytes which were cytotoxic for the specific autologous blast cell in 11 of 14 patients studied. Experiments using Daudi and Molt 4 lymphoblastoid cell lines as third-party helper cell suggest that an HLA D locus incompatability is necessary to provide effective help in this system. Cold target inhibition experiments, crossover studies between pairs of patients, and experiments with allogeneic leukemic blast cells as priming stimulus suggest that the target antigen is only present on the specific autologous blast cell.
Similar articles
-
Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells.Ger Med Sci. 2011;9:Doc18. doi: 10.3205/000141. Epub 2011 Aug 4. Ger Med Sci. 2011. PMID: 21863132 Free PMC article.
-
The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.J Immunother. 2010 Jun;33(5):523-37. doi: 10.1097/CJI.0b013e3181d87ffd. J Immunother. 2010. PMID: 20463595
-
Detection of both T-cell and Ia-like antigens on cells from patients with acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis.Cancer Res. 1979 Dec;39(12):4810-5. Cancer Res. 1979. PMID: 91428
-
Acute myelogenous leukemia blasts as accessory cells during T lymphocyte activation: possible implications for future therapeutic strategies.Leukemia. 1999 Aug;13(8):1175-87. doi: 10.1038/sj.leu.2401452. Leukemia. 1999. PMID: 10450745 Review.
-
Preclinical studies of T-cell-mediated immune responses against autologous tumor cells in patients with acute leukemia.Recent Results Cancer Res. 1993;131:215-22. doi: 10.1007/978-3-642-84895-7_19. Recent Results Cancer Res. 1993. PMID: 8210641 Review. No abstract available.
Cited by
-
The role of allogeneic cells in the stimulation of cell-mediated cytotoxicity to leukaemia cells. A family study.Cancer Immunol Immunother. 1983;15(1):39-46. doi: 10.1007/BF00199460. Cancer Immunol Immunother. 1983. PMID: 6553506 Free PMC article.
-
Regulatory functions of hapten-reactive helper and suppressor T lymphocytes. III. Amplification of a generation of tumor-specific killer T-lymphocyte activities by suppressor T-cell-depleted hapten-reactive T lymphocytes.J Exp Med. 1979 Jan 1;149(1):185-99. doi: 10.1084/jem.149.1.185. J Exp Med. 1979. PMID: 310858 Free PMC article.
-
Effect of neuraminidase treatment on serum reactivity to autologous leukemic blast cells.Cancer Immunol Immunother. 1983;15(3):194-9. doi: 10.1007/BF00199164. Cancer Immunol Immunother. 1983. PMID: 6193868 Free PMC article.
-
Autologous responses to human leukaemic cells in mixed leucocyte culture.Cancer Immunol Immunother. 1986;22(2):95-9. doi: 10.1007/BF00199121. Cancer Immunol Immunother. 1986. PMID: 2941145 Free PMC article.
-
Treatment of fresh human leukaemia cells with actinomycin D enhances their lysability by natural killer cells.Br J Cancer. 1983 Oct;48(4):507-14. doi: 10.1038/bjc.1983.223. Br J Cancer. 1983. PMID: 6626451 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials